CD274 and squamous cell carcinoma: Furthermore, in various randomized controlled trials for advanced squamous cell carcinoma of the lung, there was notable variability in the proportion of patients with high PD-L1 expression (ranging from 12.9% to 35%)9,23, which may be linked to the higher tumor mutation burden in smoking-related squamous cell carcinoma patients.